Menu Search
Equities

Maat Pharma SA

4RD:DEU

Maat Pharma SA

Actions
  • Price (EUR)6.70
  • Today's Change-0.24 / -3.46%
  • Shares traded0.00
  • 1 Year change+9.12%
  • Beta--
Data delayed at least 15 minutes, as of Sep 19 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in EURView more

In 2023, cash reserves at Maat Pharma SA fell by 10.97m. Cash Flow from Financing totalled 8.14m or 365.39% of revenues. In addition the company used 18.67m for operations while cash used for investing totalled 440.00k.
Cash flow per share-1.66
Price/Cash flow per share--
Book value per share1.76
Tangible book value per share1.65
More ▼

Balance sheet in EURView more

Maat Pharma SA appears to have a strong balance sheet with enough cash in the capital structure to pay down 100% of the liabilities.
Current ratio2.78
Quick ratio2.76
Total debt/total equity0.6877
Total debt/total capital0.4075
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.